#Type 2 diabetes

#Type 2 diabetes

According to a Sept. 16 press release, three separate doses of the new drug (6 mg, 12 mg, and 36 mg) demonstrated "significant improvements" in body weight reduction compared to a placebo at 72 weeks. "Obesity is a complex, global health challenge - and patients need treatment options that are both effective and easy to integrate into everyday life," Sean Wharton, M.D., director at Wharton Medical Clinic and lead investigator, said in the release.

Recent headlines warning of concerns such as heart risks or danger to teenagers have put a new spotlight on a diet trend that has long been the popular epitome of a healthy lifestyle: intermittent fasting. Intermittent fasting's image has been deeply tarnishedand quite rightly so, says Stefan Kabisch, a physician at the endocrinology and metabolic medicine department at ChariteUniversity Medicine Berlin. The hype was never really backed up by good data in humans.

Treatment with henagliflozin is linked to an increase in the length of telomeres, chromosomal caps that shorten over time.

A review of scientific literature by a team in South Korea reinforces the assumption that drinking coffee significantly reduces the risk of developing type 2 diabetes (T2DM). Published June 10 in the International Journal of Molecular Sciences, the study specifically explored how bioactive compounds found in coffee may diminish diabetes risk. The research team from Pukyong National University and Kyungpook National University in South Korea looked at scores of cohort studies conducted over the past several decades to determine if and how these chemical compounds - and not merely lifestyle factors, such as exercise - may affect diabetes incidence.

More than half of the calories American adults eat now come from ultraprocessed foods. From breakfast cereals to plant-based burgers and low-fat yogurt, ultraprocessed products dominate grocery aisles and dinner plates. They're cheap, convenient, and often heavily marketed as healthy. But the truth is, these industrial creations are quietly dismantling your body's ability to regulate blood sugar. Type 2 diabetes is no longer a condition that only affects older adults.

There is, however, no pharmacological treatment currently approved to treat hydrocephalus. Additionally, nearly 20 percent of patients with normal pressure hydrocephalus also have type 2 diabetes and take sodium/glucose cotransporter 2 (SGLT2) inhibitors to manage their blood sugar.